BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23187945)

  • 1. An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.
    Kahle EM; Hughes JP; Lingappa JR; John-Stewart G; Celum C; Nakku-Joloba E; Njuguna S; Mugo N; Bukusi E; Manongi R; Baeten JM;
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):339-47. PubMed ID: 23187945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.
    Irungu EM; Heffron R; Mugo N; Ngure K; Katabira E; Bulya N; Bukusi E; Odoyo J; Asiimwe S; Tindimwebwa E; Celum C; Baeten JM;
    BMC Infect Dis; 2016 Oct; 16(1):571. PubMed ID: 27751179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of transmission from HIV-infected individuals with HAART to their heterosexual serodiscordant partners.
    Del Romero J; Río I; Castilla J; Baza B; Paredes V; Vera M; Rodríguez C
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):666-72. PubMed ID: 25555636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy.
    Heffron R; Cohen CR; Ngure K; Bukusi E; Were E; Kiarie J; Mugo N; Celum C; Baeten JM;
    PLoS One; 2015; 10(12):e0145515. PubMed ID: 26720412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
    Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C;
    PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.
    Balkus JE; Brown E; Palanee T; Nair G; Gafoor Z; Zhang J; Richardson BA; Chirenje ZM; Marrazzo JM; Baeten JM
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):333-43. PubMed ID: 26918545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.
    Loutfy MR; Wu W; Letchumanan M; Bondy L; Antoniou T; Margolese S; Zhang Y; Rueda S; McGee F; Peck R; Binder L; Allard P; Rourke SB; Rochon PA
    PLoS One; 2013; 8(2):e55747. PubMed ID: 23418455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of safe sex behavior by HIV-serodiscordant heterosexual couples.
    Skurnick JH; Abrams J; Kennedy CA; Valentine SN; Cordell JR
    AIDS Educ Prev; 1998 Dec; 10(6):493-505. PubMed ID: 9883285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 prevention for HIV-1 serodiscordant couples.
    Curran K; Baeten JM; Coates TJ; Kurth A; Mugo NR; Celum C
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):160-70. PubMed ID: 22415473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
    Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
    PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.
    Kahle E; Campbell M; Lingappa J; Donnell D; Celum C; Ondondo R; Mujugira A; Fife K; Mugo N; Kapiga S; Mullins JI; Baeten JM;
    AIDS; 2014 Jan; 28(2):235-43. PubMed ID: 24413311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterosexual transmission of HIV and related risk factors among serodiscordant couples in Henan province, China.
    Wang L; Wang L; Smith MK; Li LM; Ming S; Lü J; Cao WH; He WS; Zhou JP; Wang N
    Chin Med J (Engl); 2013; 126(19):3694-700. PubMed ID: 24112166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples.
    Giannou FK; Tsiara CG; Nikolopoulos GK; Talias M; Benetou V; Kantzanou M; Bonovas S; Hatzakis A
    Expert Rev Pharmacoecon Outcomes Res; 2016 Aug; 16(4):489-99. PubMed ID: 26488070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: design and methods.
    Bavinton BR; Jin F; Prestage G; Zablotska I; Koelsch KK; Phanuphak N; Grinsztejn B; Cooper DA; Fairley C; Kelleher A; Triffitt K; Grulich AE;
    BMC Public Health; 2014 Sep; 14():917. PubMed ID: 25190360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda.
    Mugwanya KK; Whalen C; Celum C; Nakku-Joloba E; Katabira E; Baeten JM
    PLoS One; 2011; 6(7):e22254. PubMed ID: 21799805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.
    Jia Z; Mao Y; Zhang F; Ruan Y; Ma Y; Li J; Guo W; Liu E; Dou Z; Zhao Y; Wang L; Li Q; Xie P; Tang H; Han J; Jin X; Xu J; Xiong R; Zhao D; Li P; Wang X; Wang L; Qing Q; Ding Z; Chen RY; Liu Z; Shao Y
    Lancet; 2013 Oct; 382(9899):1195-203. PubMed ID: 23206835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV seroconcordance among heterosexual couples in rural KwaZulu-Natal, South Africa: a population-based analysis.
    Kim HY; Harling G; Vandormael A; Tomita A; Cuadros DF; Bärnighausen T; Tanser F
    J Int AIDS Soc; 2020 Jan; 23(1):e25432. PubMed ID: 31916420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected Thais.
    Kancheva Landolt N; Phanuphak N; Khongpetch C; Kriengsinyot R; Teeratakulpisarn S; Ubolyam S; Kerr S; Pinyakorn S; Chaithongwongwatthana S; Phanuphak P; Avihingsanon A; Ananworanich J
    AIDS Care; 2015; 27(5):587-94. PubMed ID: 25506672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.